Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DLBS1033 as Adjunctive Therapy in Acute Ischemic Stroke
NCT07121569Phase 4Completed
- Sponsor
- Universitas Sebelas Maret
- Start
- Jul 2024
- Primary completion
- Mar 2025
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of DLBS1033 in ischemic stroke, sponsored by Universitas Sebelas Maret. Started Jul 2024; status: completed.
02
Drugs
DLBS1033
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07121569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07121569.